Red cell exchange transfusion removes a patient’s sickle haemoglobin (HbS)-containing red cells and replaces them with donor cells, lowering the HbS percentage rapidly without raising blood viscosity. It is central to stroke prevention and to managing acute complications in sickle cell disease.
How it works
The exchange is driven by the fraction of cells remaining after the procedure:
FCR = target HbS / starting HbS
TBV = weight (kg) × volume factor (mL/kg)
RBC volume = TBV × haematocrit
donor RBC = RBC volume × (1 − FCR) / efficiencyHere TBV is total blood volume, estimated from weight, and the efficiency factor (commonly about 0.9) accounts for the fact that an exchange is not a perfect one-for-one replacement. Dividing the donor red cell volume by the haematocrit of the packed unit gives the whole product volume the machine must process.
Worked example
A 70 kg adult man with a haematocrit of 0.30 and a starting HbS of 80% who needs a target HbS of 25%:
- FCR = 25 / 80 = 0.313 (about 31% of the patient’s cells remain)
- TBV = 70 × 70 mL/kg = 4,900 mL
- Patient RBC volume = 4,900 × 0.30 = 1,470 mL
- Donor RBC needed = 1,470 × (1 − 0.313) / 0.90 = 1,123 mL (after efficiency adjustment)
- At a unit haematocrit of 0.65: product volume = 1,123 / 0.65 ≈ 1,727 mL, or close to six to seven standard packed cell units
Always confirm with the apheresis service. Automated exchange uses validated machine algorithms that account for patient haematocrit, target haematocrit, and exchange volume more precisely than this manual estimate.
Clinical context — when each approach is used
Exchange transfusion is chosen over simple transfusion when:
- A low HbS target is required (below 30%) that cannot be reached by simple transfusion without dangerously raising haematocrit and blood viscosity above about 36%
- The patient already has a relatively high haematocrit, leaving little room for simple top-up
- Rapid HbS reduction is needed — for acute ischaemic stroke, the target is below 30% and must be achieved urgently
Simple transfusion is appropriate when a moderate HbS reduction (down to around 50%) is acceptable, or when exchange facilities are unavailable. It cannot safely reach very low HbS percentages.
Common clinical indications for red cell exchange
| Indication | Typical HbS target |
|---|---|
| Acute ischaemic stroke | Below 30% |
| Chronic stroke prevention programme | Below 30% |
| Acute chest syndrome (moderate/severe) | Below 30–35% |
| Pre-operative preparation (major surgery) | Below 30% |
| Priapism (prolonged, refractory) | Below 30% |
| Acute multiorgan failure | Below 30% |
These are general figures from standard guidance; always follow your local haematology and apheresis protocol and confirm targets with the treating clinician.
Important caveats
This calculator reproduces the standard exchange-volume equations for educational reference and bedside cross-checking. It is not a substitute for validated apheresis machine software or for clinical judgement. Blood volume estimation from weight alone carries uncertainty of 10–15%, and individual patient variables (spleen size, baseline haematocrit variation, recent transfusion history) affect the real outcome. Automated red cell exchange on a dedicated apheresis device with a specialist supervising every parameter remains the standard of care.